Vitamin D has a small, statistically measurable effect on some cholesterol markers, but it’s not large enough for major medical organizations to recommend it as a cholesterol treatment. A large umbrella review of meta-analyses found that vitamin D supplementation modestly lowered total cholesterol and slightly raised HDL (“good”) cholesterol, while its effect on LDL (“bad”) cholesterol was not significant. The picture gets more interesting, though, when you look at who benefits most and under what conditions.
What the Pooled Evidence Shows
The most comprehensive look at this question comes from an umbrella review that combined results from multiple meta-analyses, each of which had already pooled dozens of individual trials. The findings paint a nuanced picture. Total cholesterol showed a small but statistically significant decrease across seven pooled analyses. HDL cholesterol showed a slight increase. But LDL cholesterol, the marker most doctors focus on when assessing heart risk, did not change significantly. Triglycerides also remained largely unaffected.
To put this in practical terms: the average reduction in total cholesterol across 15 meta-analyses was roughly 3 mg/dL, which is modest compared to what diet changes or statin medications can achieve. A review published in Circulation Research by the American Heart Association came to a similar conclusion, noting that while higher vitamin D levels in the blood tend to correlate with better lipid profiles, supplementation trials have shown “little evidence of a beneficial effect.” The association likely reflects the fact that people with higher vitamin D levels also tend to exercise more and eat better.
How Vitamin D Interacts With Liver Fat
Vitamin D does have plausible biological pathways for influencing cholesterol. Your liver has vitamin D receptors, and when activated, these receptors appear to help regulate how fat accumulates in liver cells. In animal studies, vitamin D improved insulin resistance in the liver and reduced fatty buildup by activating a protein involved in fat metabolism. It also influences a protein called lipoprotein lipase, which helps break down fat-carrying particles in your blood.
These mechanisms are real, but the gap between what happens in a rodent liver and what shows up on your lipid panel after taking a supplement is significant. The biological machinery exists for vitamin D to influence cholesterol processing, yet the clinical effect in humans appears too small to be clinically meaningful on its own.
The Statin Connection
One finding stands out from the broader pattern of underwhelming results. In people already taking statins, correcting a vitamin D deficiency appears to produce a more noticeable drop in LDL and total cholesterol. A study published in The Journal of Clinical Endocrinology and Metabolism found that vitamin D3 had no effect on cholesterol in people not taking statins, but showed trends toward lower LDL and total cholesterol in those on statin therapy.
The likely explanation involves cholesterol absorption. Statins work by blocking cholesterol production in the liver. Vitamin D appears to reduce cholesterol absorption in the gut, as evidenced by decreased levels of campesterol, a plant sterol that serves as a marker for how much cholesterol your intestines are absorbing. So the two may work through complementary pathways: statins reducing production while vitamin D reduces absorption. This combination effect was most pronounced in people taking atorvastatin specifically, though the study was small (19 statin users total) and the results need larger trials to confirm.
Who Might See a Difference
Subgroup analyses across multiple reviews suggest that certain groups are more likely to see lipid changes from vitamin D supplementation. People who start with a genuine deficiency (blood levels below 20 ng/mL, or 50 nmol/L) tend to show more improvement than those who already have adequate levels. This makes intuitive sense: restoring something your body is missing has a larger impact than adding more of something you already have enough of.
People with type 2 diabetes have been studied extensively. One trial using 4,000 IU per day for six months found significant reductions in triglycerides and increases in HDL, though LDL and total cholesterol didn’t budge. A systematic review of trials in people with type 2 diabetes noted that benefits were more likely to appear within the first 24 weeks of supplementation, possibly because vitamin D’s half-life in the body is about two months, meaning its effects stabilize relatively quickly. Some subgroup analyses even suggest that shorter interventions (under 12 weeks) showed more significant changes in LDL and HDL than longer ones, which may reflect early metabolic adjustments that plateau over time.
What This Means for Your Cholesterol
If you’re hoping vitamin D supplements will meaningfully lower your cholesterol numbers, the evidence doesn’t support that expectation. The American Heart Association does not recommend vitamin D supplementation for cardiovascular risk reduction, and the changes seen in clinical trials are too small to replace diet modifications, exercise, or lipid-lowering medications.
That said, if you’re already on a statin and your vitamin D levels are low, correcting that deficiency may give your statin a slight boost. And if your lipid panel is only mildly off, addressing a vitamin D deficiency is one small piece of a larger metabolic puzzle worth getting right. Vitamin D deficiency is linked to insulin resistance, inflammation, and fatty liver, all of which can worsen your lipid profile indirectly. Fixing the deficiency won’t transform your cholesterol numbers, but it removes one factor that may be working against you.
The practical takeaway: get your vitamin D levels checked, especially if you have risk factors for deficiency (limited sun exposure, darker skin, obesity, or living at higher latitudes). If you’re deficient, supplementing is worthwhile for bone health, immune function, and general metabolic support. Just don’t count on it as a cholesterol strategy.